Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities

Novel Half-sandwich Iridium OˆC (carbene)-Complexes: In Vitro and In Vivo Tumor Growth Suppression and pro-apoptosis Via ROS-mediated Cross-talk Between Mitochondria and Lysosomes

(2019) Zhishan Xu et al.   CANCER LETTERS

Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes

(2019) Wenli Ma et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression

(2019) Rong Fan et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Significant effects of counteranions on the anticancer activity of iridium(iii) complexes

(2018) Hairong Zhang et al.   CHEMICAL COMMUNICATIONS

Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features

(2018) JuanJuan Li et al.   INORGANIC CHEMISTRY

Imaging of a clickable anticancer iridium catalyst

(2018) Xiuxiu Wang et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Stereotactic radiosurgery for trigeminal neuralgia: a systematic review

(2018) Constantin Tuleasca et al.   JOURNAL OF NEUROSURGERY

Mitochondria-targeted half-sandwich rutheniumII diimine complexes: anticancer and antimetastasis via ROS-mediated signalling

(2018) Zhishan Xu et al.   Inorganic Chemistry Frontiers

Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p -Cymene Anticancer Complexes: A Structure-Activity Relationship Study

(2018) Yuliang Yang et al.   Chemistry-An Asian Journal

Lysosome-Targeted Chemotherapeutics: Half-Sandwich Ruthenium(II) Complexes That Are Selectively Toxic to Cancer Cells

(2018) Zhenzhen Tian et al.   INORGANIC CHEMISTRY

Electronic effects on reactivity and anticancer activity by half-sandwich N,N-chelated iridium(iii) complexes

(2018) Lihua Guo et al.   NEW JOURNAL OF CHEMISTRY

Dual Functional Half-Sandwich Ru(II) Complexes: Lysosome-Targeting Probes and Anticancer Agents

(2018) Zhe Liu et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Danger signals: Chemotherapy enhancers?

(2017) Thaiz Rivera Vargas et al.   IMMUNOLOGICAL REVIEWS

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

(2017) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound

(2017) Li-Juan Liu et al.   Chemical Science

Lysosomal cell death mechanisms in aging

(2016) Raquel Gómez-Sintes et al.   AGEING RESEARCH REVIEWS

Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression

(2016) Tommy Tsz-Him Fong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Ruthenium(ii) complexes with dppz: from molecular photoswitch to biological applications

(2016) Guanying Li et al.   DALTON TRANSACTIONS

Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases

(2016) Nataniel H. Lester-Coll et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents

(2015) Yi Li et al.   BIOMATERIALS

Aryl-BIAN-ligated silver(i) trifluoromethoxide complex

(2015) Shouxiong Chen et al.   DALTON TRANSACTIONS

Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes

(2014) Liang He et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling

(2014) Zhennan Zhao et al.   DALTON TRANSACTIONS

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧N-Chelated and Pyridine Ligands

(2014) Zhe Liu et al.   ORGANOMETALLICS

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

(2014) Robert Trondl et al.   Chemical Science

Economic Burden of Cancer Survivorship Among Adults in the United States

(2013) Gery P. Guy et al.   JOURNAL OF CLINICAL ONCOLOGY

Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation

(2013) M. E. Heid et al.   JOURNAL OF IMMUNOLOGY

Economic burden of cancer across the European Union: a population-based cost analysis

(2013) Ramon Luengo-Fernandez et al.   LANCET ONCOLOGY

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

(2011) Peter Friedl et al.   CELL

Tumor Metastasis: Molecular Insights and Evolving Paradigms

(2011) Scott Valastyan et al.   CELL

New tetradentate N,N,N,N-chelating α-diimine ligands and their corresponding zinc and nickel complexes: synthesis, characterisation and testing as olefin polymerisation catalysts

(2011) Lidong Li et al.   DALTON TRANSACTIONS

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

(2011) Ana-Maria Florea et al.   Cancers

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Comparison of Nephelometric, UV-Spectroscopic, and HPLC Methods for High-Throughput Determination of Aqueous Drug Solubility in Microtiter Plates

(2009) Bettina Hoelke et al.   ANALYTICAL CHEMISTRY

Lysosomal involvement in cell death and cancer

(2008) Thomas Kirkegaard et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Lysosomal membrane permeabilization in cell death

(2008) P Boya et al.   ONCOGENE